Navigation Links
Exploring new pathways to language
Date:2/17/2009

When ABC journalist Bob Woodruff was injured while reporting in Iraq in 2006, he suffered severe head injuries that caused him to lose his ability to recall and produce common words a condition called aphasia. Today, Woodruff has recovered most of his language skills thanks to intensive behavioral therapy reading and repeating words and sounds.

"The standard of care for patients with aphasia has always been and will always be speech/language therapy, but a new area is opening up that looks at what drugs can be used in combination with therapy to enhance recovery from brain damage and help the brain repair itself," said Gerry Stefanatos, D.Phil., an associate professor of communication sciences and disorders in the College of Health Professions. "We're looking at the mechanism of how this combination works it's underlying effect on patients with aphasia."

In research presented at the International Neurological Society this month, Stefanatos found that dextroamphetamine (D-AMPH), a drug commonly used to treat attention deficit hyperactivity disorder, improved the processing of speech among those suffering from Broca's aphasia and the similar Anomic aphasia.

"Improving a patient's attention and working memory may allow them to better focus and process information during therapy sessions," said Stefanatos. "Attention is critically important for learning and relearning skills, and could be helpful in forging new neural pathways in the brain."

The National Aphasia Association estimates some one million people in the United States live with aphasia, which is caused by lesions to the language centers of the brain. These lesions are often due to stroke or brain injury, but can also be the result of a brain tumor or progressive disease such as Parkinson's or Alzheimer's. Types of aphasia can range from a patient having difficulty finding and producing a word to a patient having no ability at all to speak or understand language.

Stefanatos' study looked at the use of D-AMPH in ten aphasia patients. All were also given a placebo for comparison purposes. In each condition, participants were asked to make decisions about different types of speech sounds (vowels, consonant-vowels) and complex tones. Their brain's electrical response to each was recorded via an electroencephalogram (EEG).

Those who took the D-AMPH had a strong reaction to the sounds even to consonant-vowel sounds, which are more often difficult for individuals with aphasia to process.

"This tells us that D-AMPH may help the left hemisphere of the brain regain the ability to perform its functions," said Stefanatos. "Understanding why the drug is having this effect allows us to start to think about how to tailor treatments to make them more effective or explore alternative drugs or drug combinations."

Stefanatos said he and his team chose to look at this particular drug because in patients with ADHD it has been shown to stimulate the release of dopamine and epinephrine, which help in attention and learning. But he notes that some people aren't good candidates for this particular drug.

"Now that we have a rudimentary understanding of why the drug may work to enhance the results of therapy, our next step is to look at dose effects and perhaps other drugs with more favorable side effect profiles," said Stefanatos.

Stefanatos will next study functional magnetic resonance imaging to explore the effects of D-AMPH on cerebral metabolism and where in the brain of individuals with aphasia it has the greatest effect.


'/>"/>

Contact: Renee Cree
renee.cree@temple.edu
215-707-1583
Temple University
Source:Eurekalert  

Related medicine news :

1. NIH grant supports UCSF research exploring early HIV infection
2. Exploring the Use of Techniques From Neuroscience in Todays Marketing
3. Blue Cross Blue Shield of Michigan Foundation Funds Study Exploring Link between Heart Disease and Depression
4. Exploring the Aaah ... $1 Million Grant Advances Aquatic Health Research
5. Exploring the Frontiers of Neuroscience
6. Scientists exploring new compounds to target muscular dystrophy
7. Exploring Genetic Link Between Migraines, Cardiovascular Trouble
8. Different Neural Pathways at Work Going Under, Coming Out of Anesthesia
9. Georgetown researchers find stem cell marker controls 2 key cancer pathways
10. Stem Cell Marker Controls Pair of Key Cancer Pathways
11. Breast cancer subtypes originate from different biological pathways
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Exploring new pathways to language
(Date:8/22/2017)... ... August 22, 2017 , ... “Glimpses Of Light”: ... the world. “Glimpses Of Light” is the creation of published author, J.M. Shepherd, a ... search of answers to life’s perplexing mysteries. , Shepherd shares, “Love is one of ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “Call Of ... Duty” is the creation of published author, C.S. Lizarde. Growing up on the ... untimely trials. When Carlos began to apply the Biblical keys to his life, ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... risk to health and safety. By learning and implementing best practices for containment ... In this webinar, attendees will gain a better understanding of a method for ...
(Date:8/21/2017)... ... August 21, 2017 , ... FCPX LUT Monochromatic Volume 2 is ... and easily add washed color grades to footage. A LUT is a Lookup Table ... color to the corresponding color indicated by the table. This pack comes with 60 ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... place all over the country. , Outdoor running increases exposure to ultraviolet radiation, ... an increased risk of melanoma, and only half may be adequately protecting themselves ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 2017   Second-quarter ... (GAAP) loss per share from continuing operations ... increased 16 percent to $110 million ... percent to $161 million ... continuing operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced financial ... unless otherwise noted, are to the quarter ended June 30, ... 2017 Highlights include: Revenue of $1,126 ... Total prescriptions dispensed of 220,000, compared to 241,000 ... Gross profit per prescription dispensed of $371, ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
Breaking Medicine Technology: